Table of contents
May 2002 Vol 2 No 5
In this issue
p321 | doi:10.1038/nrc816
Research Highlights
Apoptosis: Cancer cells come to a sticky end
p323 | doi:10.1038/nrc803
Therapeutics: Split personality
p324 | doi:10.1038/nrc807
Epidemiology: No-win situation
p324 | doi:10.1038/nrc810
Tumour suppressors: Brain-gain
p325 | doi:10.1038/nrc808
Tumour suppressors: Hard to stomach
p325 | doi:10.1038/nrc811
Leukaemia: Common ground
p326 | doi:10.1038/nrc802
Apoptosis: The p53 mafia
p326 | doi:10.1038/nrc804
Web Watch
Realistic goals
p326 | doi:10.1038/nrc815
News in Brief
Tumour suppressors | P53 regulation | Mouse models | Therapeutics
p327 | doi:10.1038/nrc813
Breast cancer: Checkmate
p328 | doi:10.1038/nrc809
Diagnostics: Don't take the p...
p328 | doi:10.1038/nrc812
Cancer epigenetics: It takes two
p329 | doi:10.1038/nrc806
Trial Watch
Increased death prolongs life | Colorectal cancer prevention setback
p329 | doi:10.1038/nrc814
Reviews
Modelling the molecular circuitry of cancer
William C. Hahn & Robert A. Weinberg
p331 | doi:10.1038/nrc795
Papillomaviruses and cancer: from basic studies to clinical application
Harald zur Hausen
p342 | doi:10.1038/nrc798
Oncogenic tyrosine kinases and the dna-damage response
Tomasz Skorski
p351 | doi:10.1038/nrc799
Gli and hedgehog in cancer: tumours, embryos and stem cells
Ariel Ruiz i Altaba, Pilar Sánchez & Nadia Dahmane
p361 | doi:10.1038/nrc796
Aids-related malignancies
Chris Boshoff & Robin Weiss
p373 | doi:10.1038/nrc797
Perspectives
Opinion
Effects of psychotherapy on cancer survival
David Spiegel
p383 | doi:10.1038/nrc800
Timeline
A history of prostate cancer treatment
Samuel R. Denmeade & John T. Isaacs
p389 | doi:10.1038/nrc801

